CN104258421A - Noble metal/paramagnetic metal composite nanoparticles and application thereof - Google Patents

Noble metal/paramagnetic metal composite nanoparticles and application thereof Download PDF

Info

Publication number
CN104258421A
CN104258421A CN201410464382.3A CN201410464382A CN104258421A CN 104258421 A CN104258421 A CN 104258421A CN 201410464382 A CN201410464382 A CN 201410464382A CN 104258421 A CN104258421 A CN 104258421A
Authority
CN
China
Prior art keywords
product
noble metal
dissolved
composite nanoparticle
paramagnetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410464382.3A
Other languages
Chinese (zh)
Other versions
CN104258421B (en
Inventor
张伟禄
陈佳燕
刘若望
邰玉蕾
史晓妮
吴波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wenzhou University
Original Assignee
Wenzhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wenzhou University filed Critical Wenzhou University
Priority to CN201410464382.3A priority Critical patent/CN104258421B/en
Publication of CN104258421A publication Critical patent/CN104258421A/en
Application granted granted Critical
Publication of CN104258421B publication Critical patent/CN104258421B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention discloses noble metal/paramagnetic metal composite nanoparticles and an application thereof. The noble metal/paramagnetic metal composite nanoparticles have the characteristics of good chemical stability, good contrast effect and good biocompatibility, and can be used as MRI and CT enhanced contrast agents.

Description

A kind of noble metal/paramagnetic metal composite nanoparticle and application thereof
Technical field
The present invention relates to a kind of nanosecond medical science technical field, specifically a kind of Synthesis and applications of organometallic polymer composite nanoparticle.
Technical background
Gold prepared by the scholar of home and abroad/gadolinium composite nanoparticle mainly comprises: D.P.Cormode etc. prepare in the liquid phase with Jin Weihe, phospholipid and be the high density lipoprotein nanoparticle of shell containing gadolinium part, particle diameter is about 9.7nm, can be used as fluorescence, CT and MRI multimode contrast agent; Carbamide and the GdCl such as K.W.Hu 36H 2o mol ratio be 4:1 reflux in 91 DEG C of aqueous solutions 4 hours preparation mean diameter be the Gd of 441nm 2o (CO 3) 2h 2o granule, then be polymerized with tetraethoxysilane and generate the coated Gd of silicon 2o (CO 3) 2h 2o/Si, through silane coupler modification of surfaces generation-NH 2be combined with electrostatic interaction with electronegative nanometer gold after functional group, then introduce formaldehyde reduction gold chloride system and promote golden shell to grow finally to prepare with gold to be the Gd of shell 2o (CO 3) 2h 2o/Si compound particle; D.Gerion etc. adopt Citrate Buffer first to prepare Jenner's rice glue that particle diameter is 5nm and 10nm, adding phosphatization hydrogen meter surface-active agent makes colloid-stabilised, then carry out Silanization reaction and make its external sheath silicon dioxide through subsequent treatment, then generating covalent bond with Gd-DOTA and be prepared into the Gd-DOTA-SiO that particle diameter is no more than 18nm 2-Au compound particle; Y.Chen etc. to utilize Gd-Si-DTPA grafting containing the mesopore silicon oxide enriching specific surface area to Au@mSiO 2gd-Si-DTPA-Au@mSiO is prepared in the hole of Nano capsule 2the meso-porous nano capsule of core/shell structure, can be applicable to biological bimodal imaging and comprises dark ground light scattering cell and T 1weighting MR imaging; Multilamellar organic mass shell clad nano gold such as C.Alric prepares nanoparticle, and its MRI potentiation stems from the gadolinium ion had in casing, and the gold be wrapped by is checked X-ray and had stronger absorption, and result shows that this particle is applicable to dual form imaging; The citrate ion that S.M.Nasiruzzaman etc. replace nanometer gold surface by gadolinium ion part (GdL) prepares the compound particle GdL@Au that particle diameter is about 12nm, and one of them compound particle comprises 1.4 × 10 3individual GdL, can be used as MRI and CT contrast agent; Moriggi etc. as protective agent, prepare the gold nanoclusters that Dt is coated with the smaller ligand DTTA (Dt) of sulfydryl modification, then with Gd 3+be obtained by reacting gold/gadolinium composite nanoparticle for MRI contrast agent.
Summary of the invention
First object of the present invention is to provide that a kind of chemical stability is good, the noble metal/paramagnetic metal composite nanoparticle of contrasting effects and good biocompatibility.
Second object of the present invention is to provide described noble metal/paramagnetic metal composite nanoparticle strengthens contrast medium application as MRI and CT.
For achieving the above object, the present invention adopts following technical scheme:
Noble metal involved in the present invention/paramagnetic metal composite nanoparticle is made up of noble metal nano particles, organic bonding units and paramagnetic metal, and its preparation method comprises the following steps:
(1) polysuccinimide is dissolved in N, in dinethylformamide (DMF), be warming up to 30 ~ 65 DEG C under nitrogen protection and stirring, then add compd A, stop heating after 24-48 hour, reactant mixture obtains product I after dialysing, revolving steaming, drying; Described compd A is 1-alkyl azide amine, and wherein the carbon atom number of alkyl is at 2 ~ 6;
(2) product I is dissolved in N, in dinethylformamide, nitrogen protection and dropping compd B and catalyst n under stirring, N-diisopropylethylamine, stop heating in 30 ~ 80 DEG C of reactions after 24-48 hour, reactant mixture through dialysis, revolve steaming, drying obtains product II; Described compd B is p-aminophenyl thiophenol or L-cysteine hydrochloride or Mercaptamine;
(3) by the N shown in product II and formula (I) 2-(4-alkynyl)-diethylenetriamines-four tert-butyl ester is dissolved in oxolane, add the sodium ascorbate of brand-new and the aqueous solution of copper sulphate pentahydrate again, under room temperature, react extract and separate organic layer after 2-4 hour, then through dialysis, revolve steaming, drying obtains product III;
(4) product III is dissolved in dichloromethane, under stirring, slowly drips trifluoroacetic acid, stop after finishing room temperature reaction 24-48 hour, revolve and steam removing dichloromethane and trifluoroacetic acid, add ether ultrasonic disperse, obtain product IV through separation, washing, drying;
(5) be dissolved in ultra-pure water by product IV, drip the aqueous solution of Compound C, drip complete adjust ph to 8-9, then stir 1-2 hour, reactant mixture obtains product V through dialysis, drying; Described Compound C is selected from paramagnetic lanthanide series metal chloride;
(6) preparation gold or Nano silver grain;
(7) product V is dissolved in dimethyl sulfoxine (DMSO), and add step (6) freshly prepd gold or Nano silver grain, after reacting 12-24 hour under room temperature, reactant mixture through dialysis, revolve steaming, drying obtains end product noble metal/paramagnetic metal composite nanoparticle.
Further, in step (1), the molar ratio of polysuccinimide and compd A is 1:0.2 ~ 0.5.
Further, the molar ratio of product I, compd B, DIPEA is 1:0.8 ~ 0.5:0.8 ~ 0.5.
Further, in step (3), product II and N 2the molar ratio of-(4-alkynyl)-diethylenetriamines-four tert-butyl ester, sodium ascorbate, copper sulfate is 1:0.2 ~ 0.5:0.2 ~ 0.5:0.2 ~ 0.5.
Further, in step (4), the molar ratio of product III and trifluoroacetic acid is 1:4 ~ 8.
Further, in step (5), the molar ratio of product IV and Compound C is 1:1 ~ 2.
Further, in step (6), the preparation method of gold or Nano silver grain is conventional reduction method, those skilled in the art can complete preparation according to prior art, such as can be prepared as follows: appropriate precious metal chemical complex (auric chloride, perchloric acid gold, silver nitrate etc.) is dissolved in ultra-pure water, proper amount of sodium citrate or sodium borohydride is added rapidly after being heated to boiling, react and be cooled to room temperature after 5-10 minute, continue to stir after 0.5-1 hour and stop, obtaining noble metal nano colloid solution.Wherein the mol ratio of precious metal chemical complex and sodium citrate or sodium borohydride is 1:4 ~ 8.
Further, in step (7), the molar ratio of the nano noble metal particles in product V and nano-noble metal colloid solution is 1:8 ~ 32.
Present invention also offers described noble metal/paramagnetic metal composite nanoparticle strengthens contrast medium application as MRI and CT.
In the present invention, the molecular weight of macromolecular compound is all the mean molecule quantity adopting gel chromatography to record.
Compared with prior art, the present invention is successively reacted with polysuccinimide by compd A and compd B, obtain the copolymer containing multiple nitrine functional group and multiple mercapto functional group, and paramagnetic metal ion is introduced in this copolymer, obtain macromole paramagnetic metal coordination compound, and utilize Au-S key or Ag-S key by this coordination compound and Precious Metals-Gold or nano grain of silver sublink, thus prepare a kind of chemically stable noble metal/paramagnetic metal composite nanoparticle.This compound particle has following advantage: (1) is bonding units with macromolecular chain, adds the number of sites of gadolinium ion chelating, contributes to improving Relaxivity; (2) macromolecular chain exists multiple sulfydryl, stable chemical bond can be formed with noble metal nano particles, contribute to improving chemical stability; (3) noble metal nano particles not only can as the assembly platform of bonding units, simultaneously because its special permanent magnetism also can be used as signal amplification unit, the use of polysuccinimide makes this compound particle have good biocompatibility in addition, is expected to agent as a comparison and is applied to medical imaging field.
Accompanying drawing explanation
Fig. 1 is the structural representation of gold/gadolinium composite nanoparticle that embodiment 1 obtains.
Fig. 2 is transmission electron microscope (TEM) image of gold/gadolinium composite nanoparticle that embodiment 1 obtains.
Fig. 3 is the MRI image of gold/gadolinium composite nanoparticle that embodiment 1 obtains, from left to right be followed successively by gold/gadolinium composite nanoparticle, not containing tester (the product V namely in embodiment 1), the Magnevist Solution injection (Beilu Pharmaceutical Industry Co., Ltd., Beijing) of gold, concentration is followed successively by 1.00,0.50,0.25,0.125,0.0625,0.0 × 10 from top to bottom -3mmolL -1.
Fig. 4 is the CT image of gold/gadolinium composite nanoparticle that embodiment 1 obtains, and 1-6 concentration is followed successively by 1.00,0.50,0.25,0.125,0.0625,0.0 × 10 -3mmolL -1.
Detailed description of the invention
Following instance is provided in order to set forth spy of the present invention further.Obvious embodiments of the present invention are not limited to following embodiment.
Embodiment 1
Step a; polysuccinimide (molecular weight 20000) 1.0g is dissolved in 5mL N; in dinethylformamide (DMF) solvent; and drop in 100ml there-necked flask; stir; logical nitrogen protection, adds 0.4g1-nitrine propylamine after being warming up to 60 DEG C, react after 24 hours and stop heating.Reactant mixture is transferred to molecular cut off be 3500 bag filter dialyse in DMF 48 hours, rotary evaporation is removed DMF and is obtained darkorange thick liquid, after drying under reduced pressure product I.
Step b, is dissolved in 1.25g product I in 5mL DMF, and logical nitrogen protection, stirs and add 1.13g Mercaptamine, 1.32g DIPEA, and 60 DEG C of reactions stopped heating after 24 hours.Mixture after reaction being transferred to molecular cut off is dialyse 48 hours in ultra-pure water in 3500 bag filters, and rotary evaporation is removed most of water postlyophilization and obtained pale pink solid product II.
Step c, gets 1.25g product II and 3.90g N 2-(4-alkynyl)-diethylenetriamines-four tert-butyl ester is dissolved in 5mL oxolane, then adds freshly prepared 1molL -1sodium ascorbate and each 1mL of copper sulphate pentahydrate aqueous solution, react under room temperature after 2 hours and add 10mL water, 10mL dichloromethane, stir and be transferred to separatory funnel after 2 minutes, retain organic layer, after dialysing 24 hours in dichloromethane, rotary evaporation removing dichloromethane, obtains product III after drying under reduced pressure.
Steps d, 3.0g product III is dissolved in 5mL dichloromethane, stir, slowly drip 2mL trifluoroacetic acid under room temperature, room temperature reaction stopped after 24 hours, revolved after steaming removing dichloromethane and trifluoroacetic acid, add 10mL ether ultrasonic disperse 10 minutes, obtain white solid powder, then wash three times with absolute ether, after drying under reduced pressure, obtain product IV.
Step e, is dissolved in 2.5g product IV in 5mL ultra-pure water, by 0.7g GdCl 3soluble in water, and point three droppings, dropwise rear saturated solution of sodium bicarbonate adjust ph is 8-9 at every turn.Stir, after 1 hour, reactant mixture is moved into bag filter, after dialysing 48 hours in water, lyophilization obtains product V.
Step f, is dissolved in 0.42g gold chloride in 20mL ultra-pure water, is heated to boiling, adds rapidly 1.00g sodium citrate, react and be cooled to room temperature after 5 minutes, continues stirring and stops after 0.5 hour, obtain nano gold sol product VI.
Step g, 0.2g product V is dissolved in 2mL DMSO, and drip 10mL concentration 0.001mol/L product VI, reacting under room temperature moved in 3500Da bag filter after 12 hours, dialyse 24 hours in ultra-pure water, revolve steaming and to remove after most of water under 3000 revs/min of revolutions centrifugalize 30 minutes, get upper solution and concentrate postlyophilization and obtain end product.
End product is configured to variable concentrations aqueous solution (1.00,0.50,0.25,0.125,0.0625,0.0mmolL -1).Then be placed in small test tube, test imaging effect respectively in nuclear magnetic resonance imaging instrument and computed tomographic scanner.Result shows, in embodiment 1, composite nanoparticle possesses MRI reinforced effects (as Fig. 3), and CT imaging effect (as Fig. 4).Its MRI relaxation rate is 47.6mM -1s -1, the CT value of 1mM is 59.5/0.8.
Embodiment 2
Step a; polysuccinimide (molecular weight 20000) 1.0g is dissolved in 5mL N; in dinethylformamide (DMF) solvent; and drop in 100ml there-necked flask; stir; logical nitrogen protection, adds 0.4g1-nitrine propylamine after being warming up to 60 DEG C, react after 24 hours and stop heating.Reactant mixture is transferred to molecular cut off be 3500 bag filter dialyse in DMF 48 hours, rotary evaporation is removed DMF and is obtained darkorange thick liquid, after drying under reduced pressure product I.
Step b, is dissolved in 1.25g product I in 5mL DMF, and logical nitrogen protection, stirs and add 1.13g Mercaptamine, 1.32g DIPEA, and 60 DEG C of reactions stopped heating after 24 hours.Mixture after reaction being transferred to molecular cut off is dialyse 48 hours in ultra-pure water in 3500 bag filters, and rotary evaporation is removed most of water postlyophilization and obtained pale pink solid product II.
Step c, gets 1.25g product II and 3.90g N 2-(4-alkynyl)-diethylenetriamines-four tert-butyl ester is dissolved in 5mL oxolane, then adds freshly prepared 1molL -1sodium ascorbate and each 1mL of copper sulphate pentahydrate aqueous solution, react under room temperature after 2 hours and add 10mL water, 10mL dichloromethane, stir and be transferred to separatory funnel after 2 minutes, retain organic layer, after dialysing 24 hours in dichloromethane, rotary evaporation removing dichloromethane, obtains product III after drying under reduced pressure.
Steps d, 3.0g product III is dissolved in 5mL dichloromethane, stir, slowly drip 2mL trifluoroacetic acid under room temperature, room temperature reaction stopped after 24 hours, revolved after steaming removing dichloromethane and trifluoroacetic acid, add 10mL ether ultrasonic disperse 10 minutes, obtain white solid powder, then wash three times with absolute ether, after drying under reduced pressure, obtain product IV.
Step e, is dissolved in 2.5g product IV in 5mL ultra-pure water, by 0.7g GdCl 3soluble in water, and point three droppings, dropwise rear saturated solution of sodium bicarbonate adjust ph is 8-9 at every turn.Stir, after 1 hour, reactant mixture is moved into bag filter, after dialysing 48 hours in water, lyophilization obtains product V.
25mL concentration is 2 × 10 by step f with vigorous stirring in cryosel bath -3molL -1 silver nitrate solutionbeing added drop-wise to 25mL concentration is 8 × 10 -3molL -1in sodium borohydride aqueous solution, react and obtain Nano silver grain hydrosol product VI after 30 minutes.
Step g, 0.2g product V is dissolved in 2mL DMSO, and drip 10mL concentration 0.001mol/L product VI, reacting under room temperature moved in 3500Da bag filter after 12 hours, dialyse 24 hours in ultra-pure water, revolve steaming and to remove after most of water under 3000 revs/min of revolutions centrifugalize 30 minutes, get upper solution and concentrate postlyophilization and obtain end product.
Embodiment 3
Step a, is dissolved in polysuccinimide 1.0g in 5mLDMF solvent, and drops in 100ml there-necked flask, stirs, and logical nitrogen protection, adds 0.4g1-nitrine propylamine after being warming up to 60 DEG C, reacts after 24 hours and stops heating.Reactant mixture is transferred to molecular cut off be 3500 bag filter dialyse in DMF 48 hours, rotary evaporation is removed DMF and is obtained darkorange thick liquid, after drying under reduced pressure product I.
Step b, is dissolved in 5mL DMF solvent by 1.25g product I, logical nitrogen protection, stirring adds 2.5g is to amino phenylmercaptan., 1.32g DIPEA, reactant mixture to be transferred to molecular cut off by 60 DEG C of reactions after 24 hours be dialyse 48 hours in ultra-pure water in 3500 bag filters, and rotary evaporation is removed most of water postlyophilization and obtained product II.
Step c, gets 1.0g product II and 3.90g N 2-(4-alkynyl)-diethylenetriamines-four tert-butyl ester is dissolved in 5mL oxolane, then adds freshly prepared 1molL -1sodium ascorbate and each 1mL of copper sulphate pentahydrate aqueous solution, react under room temperature after 2 hours and add 10mL water, 10mL dichloromethane, stir and be transferred to separatory funnel after 2 minutes, retain organic layer, after dialysing 24 hours in dichloromethane, rotary evaporation removing dichloromethane, obtains product III after drying under reduced pressure.
Steps d, 3.0g product III is dissolved in 5mL dichloromethane, stir, slowly drip 2mL trifluoroacetic acid under room temperature, room temperature reaction stopped after 24 hours, revolved after steaming removing dichloromethane and trifluoroacetic acid, add 10mL ether ultrasonic disperse 10 minutes, obtain white solid powder, then wash three times with absolute ether, after drying under reduced pressure, obtain product IV.
Step e, is dissolved in 2.5g product IV in 5mL ultra-pure water, by 0.7g GdCl 3soluble in water, and point three droppings, dropwise rear saturated solution of sodium bicarbonate adjust ph is 8-9 at every turn.Stir, after 1 hour, reactant mixture is moved into bag filter, after dialysing 48 hours in water, lyophilization obtains product V.
Step f, is dissolved in 0.42g gold chloride in 20mL ultra-pure water, is heated to boiling, adds rapidly 1.00g sodium citrate, react and be cooled to room temperature after 5 minutes, continues stirring and stops after 0.5 hour, obtain nano gold sol product VI.
Step g, 0.2g product V is dissolved in 2mL DMSO, and drip 10mL concentration 0.001mol/L product VI, reacting under room temperature moved in 3500Da bag filter after 12 hours, dialyse 24 hours in ultra-pure water, revolve steaming and to remove after most of water under 3000 revs/min of revolutions centrifugalize 30 minutes, get upper solution and concentrate postlyophilization and obtain end product.
Embodiment 4
Step a, is dissolved in polysuccinimide 1.0g in 5mL DMF solvent, and drops in 100ml there-necked flask, stirs, and logical nitrogen protection, adds 0.2g1-nitrine propylamine after being warming up to 60 DEG C, reacts after 24 hours and stops heating.Reactant mixture is transferred to molecular cut off be 3500 bag filter dialyse in DMF 48 hours, rotary evaporation is removed DMF and is obtained darkorange thick liquid, after drying under reduced pressure product I.
Step b, is dissolved in 5mL DMF solvent by 1.25g product I, logical nitrogen protection, stirring adds 1.25g to amino phenylmercaptan., 1.32g DIPEA, reactant mixture to be transferred to molecular cut off by 60 DEG C of reactions after 24 hours be dialyse 48 hours in ultra-pure water in 3500 bag filters, and rotary evaporation is removed most of water postlyophilization and obtained product II.
Step c, gets 1.0g product II and 3.90g N 2-(4-alkynyl)-diethylenetriamines-four tert-butyl ester is dissolved in 5mL oxolane, then adds freshly prepared 1molL -1sodium ascorbate and each 1mL of copper sulphate pentahydrate aqueous solution, react under room temperature after 2 hours and add 10mL water, 10mL dichloromethane, stir and be transferred to separatory funnel after 2 minutes, retain organic layer, after dialysing 24 hours in dichloromethane, rotary evaporation removing dichloromethane, obtains product III after drying under reduced pressure.
Steps d, 3.0g product III is dissolved in 5mL dichloromethane, stir, slowly drip 2mL trifluoroacetic acid under room temperature, room temperature reaction stopped after 24 hours, revolved after steaming removing dichloromethane and trifluoroacetic acid, add 10mL ether ultrasonic disperse 10 minutes, obtain white solid powder, then wash three times with absolute ether, after drying under reduced pressure, obtain product IV.
Step e, is dissolved in 2.5g product IV in 5mL ultra-pure water, by 0.7g GdCl 3soluble in water, and point three droppings, dropwise rear saturated solution of sodium bicarbonate adjust ph is 8-9 at every turn.Stir, after 1 hour, reactant mixture is moved into bag filter, after dialysing 48 hours in water, lyophilization obtains product V.
25mL concentration is 2 × 10 by step f with vigorous stirring in cryosel bath -3molL -1 silver nitrate solutionbeing added drop-wise to 25mL concentration is 8 × 10 -3molL -1in sodium borohydride aqueous solution, react and obtain Nano silver grain hydrosol product VI after 30 minutes.
Step g, 0.2g product V is dissolved in 2mL DMSO, and drip 10mL concentration 0.001mol/L product VI, reacting under room temperature moved in 3500Da bag filter after 12 hours, dialyse 24 hours in ultra-pure water, revolve steaming and to remove after most of water under 3000 revs/min of revolutions centrifugalize 30 minutes, get upper solution and concentrate postlyophilization and obtain end product.

Claims (9)

1. noble metal/paramagnetic metal composite nanoparticle, be made up of noble metal nano particles, organic bonding units and paramagnetic metal, its preparation method comprises the following steps:
(1) polysuccinimide is dissolved in N, in dinethylformamide (DMF), be warming up to 30 ~ 65 DEG C under nitrogen protection and stirring, then add compd A, stop heating after 24-48 hour, reactant mixture obtains product I after dialysing, revolving steaming, drying; Described compd A is 1-alkyl azide amine, and wherein the carbon atom number of alkyl is at 2 ~ 6;
(2) product I is dissolved in N, in dinethylformamide, nitrogen protection and dropping compd B and catalyst n under stirring, N-diisopropylethylamine, stop heating in 30 ~ 80 DEG C of reactions after 24-48 hour, reactant mixture through dialysis, revolve steaming, drying obtains product II; Described compd B is p-aminophenyl thiophenol or L-cysteine hydrochloride or Mercaptamine;
(3) by the N shown in product II and formula (I) 2-(4-alkynyl)-diethylenetriamines-four tert-butyl ester is dissolved in oxolane, add the sodium ascorbate of brand-new and the aqueous solution of copper sulphate pentahydrate again, under room temperature, react extract and separate organic layer after 2-4 hour, then through dialysis, revolve steaming, drying obtains product III;
(4) product III is dissolved in dichloromethane, under stirring, slowly drips trifluoroacetic acid, stop after finishing room temperature reaction 24-48 hour, revolve and steam removing dichloromethane and trifluoroacetic acid, add ether ultrasonic disperse, obtain product IV through separation, washing, drying;
(5) be dissolved in ultra-pure water by product IV, drip the aqueous solution of Compound C, drip complete adjust ph to 8-9, then stir 1-2 hour, reactant mixture obtains product V through dialysis, drying; Described Compound C is selected from paramagnetic lanthanide series metal chloride;
(6) preparation gold or Nano silver grain;
(7) product V is dissolved in dimethyl sulfoxine (DMSO), and add step (6) freshly prepd gold or Nano silver grain, after reacting 12-24 hour under room temperature, reactant mixture through dialysis, revolve steaming, drying obtains end product noble metal/paramagnetic metal composite nanoparticle.
2. noble metal/paramagnetic metal composite nanoparticle as claimed in claim 1, it is characterized in that: in step (1), the molar ratio of polysuccinimide and compd A is 1:0.2 ~ 0.5.
3. noble metal/paramagnetic metal composite nanoparticle as claimed in claim 1, it is characterized in that: in step (2), the molar ratio of product I, compd B, DIPEA is 1:0.8 ~ 0.5:0.8 ~ 0.5.
4. noble metal/paramagnetic metal composite nanoparticle as claimed in claim 1, is characterized in that: in step (3), product II and N 2the molar ratio of-(4-alkynyl)-diethylenetriamines-four tert-butyl ester, sodium ascorbate, copper sulfate is 1:0.2 ~ 0.5:0.2 ~ 0.5:0.2 ~ 0.5.
5. noble metal/paramagnetic metal composite nanoparticle as claimed in claim 1, it is characterized in that: in step (4), the molar ratio of product III and trifluoroacetic acid is 1:4 ~ 8.
6. noble metal/paramagnetic metal composite nanoparticle as claimed in claim 1, it is characterized in that: in step (5), the molar ratio of product IV and Compound C is 1:1 ~ 2.
7. noble metal/paramagnetic metal composite nanoparticle as claimed in claim 1, is characterized in that: in step (7), and the molar ratio of the nano noble metal particles in product V and nano-noble metal colloid solution is 1:8 ~ 32.
8. noble metal/paramagnetic metal composite nanoparticle as claimed in claim 1 strengthens the application of contrast medium as MRI.
9. noble metal/paramagnetic metal composite nanoparticle as claimed in claim 1 strengthens the application of contrast medium as CT.
CN201410464382.3A 2014-09-12 2014-09-12 A kind of noble metal/paramagnetic metal composite nanoparticle and application thereof Expired - Fee Related CN104258421B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410464382.3A CN104258421B (en) 2014-09-12 2014-09-12 A kind of noble metal/paramagnetic metal composite nanoparticle and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410464382.3A CN104258421B (en) 2014-09-12 2014-09-12 A kind of noble metal/paramagnetic metal composite nanoparticle and application thereof

Publications (2)

Publication Number Publication Date
CN104258421A true CN104258421A (en) 2015-01-07
CN104258421B CN104258421B (en) 2016-09-21

Family

ID=52150074

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410464382.3A Expired - Fee Related CN104258421B (en) 2014-09-12 2014-09-12 A kind of noble metal/paramagnetic metal composite nanoparticle and application thereof

Country Status (1)

Country Link
CN (1) CN104258421B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107573513A (en) * 2017-08-28 2018-01-12 济南大学 A kind of silver-bearing copper different metal cluster compound and its preparation method and application
CN111166023A (en) * 2020-01-23 2020-05-19 中国计量大学 Pearl brightening liquid and preparation method thereof, pearl brightening method and brightening device

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101620910A (en) * 2008-07-01 2010-01-06 中国科学院成都有机化学有限公司 Preparation method and application of core-shell magnetic/gold nanocomposite particles
EP2433726A1 (en) * 2010-09-28 2012-03-28 National Cheng Kung University CT/MRI dual-modality molecular imaging contrast agent and method for manufacturing the same
WO2012177039A2 (en) * 2011-06-22 2012-12-27 Hanwha Chemical Corporation. Mri contrast agent for lymphography based on iron oxide nanoparticles and method for imaging lymph node using the same
CN104028181A (en) * 2014-04-24 2014-09-10 温州大学 Precious metal/paramagnetic metal composite nanoparticle with core-shell structure and application thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101620910A (en) * 2008-07-01 2010-01-06 中国科学院成都有机化学有限公司 Preparation method and application of core-shell magnetic/gold nanocomposite particles
EP2433726A1 (en) * 2010-09-28 2012-03-28 National Cheng Kung University CT/MRI dual-modality molecular imaging contrast agent and method for manufacturing the same
WO2012177039A2 (en) * 2011-06-22 2012-12-27 Hanwha Chemical Corporation. Mri contrast agent for lymphography based on iron oxide nanoparticles and method for imaging lymph node using the same
CN104028181A (en) * 2014-04-24 2014-09-10 温州大学 Precious metal/paramagnetic metal composite nanoparticle with core-shell structure and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
M. F. FERREIRA ET AL.: "Gold nanoparticles functionalised with stable, fast water exchanging Gd3+ chelates as high relaxivity contrast agents for MRI", 《DALTON TRANS.》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107573513A (en) * 2017-08-28 2018-01-12 济南大学 A kind of silver-bearing copper different metal cluster compound and its preparation method and application
CN111166023A (en) * 2020-01-23 2020-05-19 中国计量大学 Pearl brightening liquid and preparation method thereof, pearl brightening method and brightening device

Also Published As

Publication number Publication date
CN104258421B (en) 2016-09-21

Similar Documents

Publication Publication Date Title
Peng et al. Targeted tumor CT imaging using folic acid-modified PEGylated dendrimer-entrapped gold nanoparticles
US11497818B2 (en) Ultrafine nanoparticles comprising a functionalized polyorganosiloxane matrix and including metal complexes; method for obtaining same and uses thereof in medical imaging and/or therapy
Cai et al. Dendrimer‐assisted formation of Fe3O4/Au nanocomposite particles for targeted dual mode CT/MR imaging of tumors
Li et al. Facile one-pot synthesis of Fe3O4@ Au composite nanoparticles for dual-mode MR/CT imaging applications
Zhang et al. X-ray-triggered NO-released Bi–SNO nanoparticles: all-in-one nano-radiosensitizer with photothermal/gas therapy for enhanced radiotherapy
Bonitatibus Jr et al. Preclinical assessment of a zwitterionic tantalum oxide nanoparticle X-ray contrast agent
Peng et al. Antiferromagnetic iron nanocolloids: A new generation in vivo T 1 MRI contrast agent
Carniato et al. Gd‐based mesoporous silica nanoparticles as MRI probes
CN102294038B (en) Method for preparing computed tomography (CT)/magnatic resonance imaging (MRI) bimodal imaging contrast agent based on dendrimers
Gao et al. Overcoming T Cell Exhaustion via Immune Checkpoint Modulation with a Dendrimer‐Based Hybrid Nanocomplex
CN108478815B (en) Preparation method of pyridine-modified dendrimer copper complex hybrid nanomaterial
KR20210059683A (en) Particles Comprising Bilirubin Derivatives And Metals
Buczkowski et al. Study of the interactions of PAMAM G3-NH2 and G3-OH dendrimers with 5‐fluorouracil in aqueous solutions
WO2006088958A2 (en) Encapsulated (chelate or ligand) dendritic polymers
CN106466488A (en) There is ultra-fine magnetic core-shell nano material and its preparation and the application of tumor cell targeting
Xiao et al. A dendrimer-based dual radiodense element-containing nanoplatform for targeted enhanced tumor computed tomography imaging
Wang et al. A class of water-soluble Fe (III) coordination complexes as T 1-weighted MRI contrast agents
CN104258421B (en) A kind of noble metal/paramagnetic metal composite nanoparticle and application thereof
KR20080066999A (en) Nanoparticles used as contrasting agents in magnetic resonance imaging
Simão et al. Laser-synthesized ligand-free Au nanoparticles for contrast agent applications in computed tomography and magnetic resonance imaging
Elbarbary et al. Magnetic 99mTc-core-shell of polyethylene glycol/polyhydroxyethyl methacrylate based on Fe3O4 nanoparticles: Radiation synthesis, characterization and biodistribution study in tumor bearing mice
CN107929756B (en) porous Prussian blue nano-particles coated with aminated silicon dioxide as well as preparation method and application of porous Prussian blue nano-particles
CN104302731B (en) Rare earth oxide particles and application thereof, the particularly purposes in imaging
CN107753960A (en) A kind of polymeric metal oxide compound and preparation method and application
CN102481381A (en) Nanoparticle contrast agents for diagnostic imaging

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160921

Termination date: 20180912